Core Viewpoint - The ongoing dispute between Aikang Guobin and lawyer Zhang Xiaoling centers around allegations of misdiagnosis and the integrity of health check reports, with both parties engaging in legal actions against each other [1][3][4]. Group 1: Dispute Details - Zhang Xiaoling was diagnosed with late-stage kidney cancer after ten years of health check reports from Aikang Guobin showing "no abnormalities," leading her to question the validity of the checks [1]. - Aikang Guobin has denied any wrongdoing, asserting that there were no misdiagnoses or false health checks, and has initiated legal proceedings against Zhang Xiaoling [1][2]. - The dispute has escalated, with both parties filing lawsuits against each other, indicating a significant conflict [1][3]. Group 2: Medical Reports and Responses - During a media briefing, Aikang Guobin presented parts of Zhang Xiaoling's 2023 health check report, which indicated potential kidney issues and recommended further examinations [2]. - Aikang Guobin clarified that blood samples are typically only preserved for 1-7 days, making it impossible to retain samples from the past ten years [2]. - Zhang Xiaoling has requested the disclosure of her health check data and related information, while Aikang Guobin stated that such disclosure requires her written authorization [3]. Group 3: Industry Context - The health check service market in China has seen a compound annual growth rate of 11.1% from 2016 to 2020, with projections estimating the market size to reach 394.3 billion yuan by 2025 [5]. - Aikang Group operates multiple brands, providing a range of health management services across 170 centers in 54 cities as of May 2025 [5]. - The founder of Aikang Group has previously highlighted issues within the health check industry, emphasizing the distinction between health checks and medical consultations [6][7].

Core Viewpoint - The CEO of Aikang Group, Zhang Ligang, emphasized that low-cost health check-ups cannot be expected to detect all diseases, and that there is a significant difference between health check-ups and medical consultations [4][7][8] Group 1: Company Response to Allegations - Aikang Group's senior vice president, Zhou Xiaojing, responded to allegations of "fake health check-ups" made by lawyer Zhang Xiaoling, stating that her claims have severely damaged the company's reputation and trust in the health check-up industry [6][12] - Aikang Group announced that it has filed a lawsuit against Zhang Xiaoling for defamation, seeking to clarify the facts and restore its reputation [6][12] - The company asserted that it will not compromise on the professionalism of its services, regardless of the cost of health check-up packages [8] Group 2: Clarification of Health Check-up vs. Medical Consultation - Zhang Ligang explained that health check-ups are primarily for disease prevention and risk identification, while medical consultations involve specific diagnoses and treatments, which are generally more expensive [7][8] - The company highlighted that the public often misunderstands the boundaries between health check-ups and medical consultations, leading to misconceptions about the effectiveness of low-cost check-ups [4][7] Group 3: Background of Allegations - Zhang Xiaoling, a lawyer, claimed that after ten years of health check-ups at Aikang, she was diagnosed with advanced kidney cancer, raising questions about the accuracy of her previous check-ups [9][11] - Aikang Group stated that the health check-up reports indicated potential issues, and they are willing to collaborate with third-party experts to analyze the situation [11][12]

Core Viewpoint - The CEO of Aikang Group, Zhang Ligang, emphasized the clear distinction between health check-ups and medical consultations, stating that health check-ups are primarily for disease prevention and risk identification, while medical consultations are for definitive diagnosis and treatment [1][4]. Group 1: Media Misrepresentation - Some media outlets misinterpreted Zhang Ligang's comments, reducing them to the phrase "don't expect a few hundred yuan check-up to detect any illness," which stripped the context and distorted the original meaning [1][2][4]. - The media's simplification of the discussion on the differences between health check-ups and medical consultations misled the public regarding the value of health check-ups, violating principles of objective and comprehensive reporting [2][4]. Group 2: Commitment to Professionalism - Aikang Group asserts that it will not compromise the professionalism of its services, regardless of the price of health check-up packages, maintaining a commitment to customer-centric health management services [2][5]. - The company aims to provide rigorous health management services and emphasizes that the cost of check-up packages does not affect the quality of service provided [2][5].

Core Viewpoint - The company Aikang Guobin held a media briefing to address the incident involving a patient, Ms. Zhang, who claimed that her kidney cancer was not detected during ten years of health check-ups, asserting that there were no diagnostic errors or "fake health checks" [1][3]. Group 1: Company Response - Aikang Guobin stated that there were no flaws in Ms. Zhang's kidney examinations, and they have filed a lawsuit against her for spreading false information, which has been accepted by the court [3][7]. - The founder and CEO, Zhang Ligang, emphasized that health check-ups should not be equated with medical diagnoses, highlighting the public's misunderstanding of the boundaries between health checks and medical evaluations [3][6]. - The company provided evidence that all medical personnel were certified, and all equipment and reagents complied with national regulations, asserting that the testing process adhered to quality control standards [6][7]. Group 2: Industry Context - The health check-up industry has faced criticism for over-promoting certain tests, such as tumor marker screenings, which are often misunderstood by the public [3][5]. - Experts have indicated that tumor markers are primarily used for auxiliary diagnosis and are not reliable for early cancer detection, as they can be present in healthy individuals or benign conditions [5][6]. - The controversy surrounding tumor markers, particularly the "carcinoembryonic antigen" (CEA) test, was a focal point of Ms. Zhang's claims, which Aikang Guobin refuted by stating that there is no recognized correlation between CEA levels and kidney cancer [5][6]. Group 3: Legal and Ethical Implications - Aikang Guobin's legal action against Ms. Zhang is aimed at clarifying the facts and restoring the company's reputation, as they believe her claims have unjustly harmed the company and the industry [7]. - The incident highlights the need for greater transparency and regulation within the health check-up industry, as well as the importance of educating the public about the limitations of health screenings [7].

Core Viewpoint - The controversy surrounding Aikang Guobin's health check services has intensified following allegations from lawyer Zhang Xiaoling regarding missed cancer diagnoses, leading to a formal lawsuit by the company against her for defamation [1][5][14] Group 1: Company Response - Aikang Guobin reiterated that there were no missed or erroneous diagnoses in Zhang's health checks and has filed a lawsuit for defamation based on her claims of "fabricating facts and spreading rumors" [1][5] - The company presented Zhang's 2023 health check report, which indicated potential issues but recommended further examinations, emphasizing the importance of regular follow-ups [3][4] - Aikang Guobin's CEO, Zhang Ligang, clarified that health checks are meant for risk assessment rather than definitive diagnoses, highlighting the limitations of low-cost health check packages [6][10] Group 2: Public and Media Reaction - Zhang Xiaoling has publicly welcomed the lawsuit and has called for Aikang Guobin to disclose her ten years of health check data, including ultrasound images and technician qualifications [4][5] - The company's statements regarding the nature of health checks have sparked significant public debate, with some media misrepresenting the CEO's comments, leading to accusations of defamation against the company [6][11][12] - Aikang Guobin reported a high volume of complaints on platforms like Black Cat Complaints, with 76.2% attributed to uncontrollable factors, while only 2.5% were related to medical service issues [14]

Core Viewpoint - The controversy surrounding the comments made by the CEO of iKang Group regarding the limitations of health check-ups has sparked significant media attention and misinterpretation [2][3][4]. Group 1: Clarification of Health Check-ups vs. Medical Consultations - The CEO of iKang Group, Zhang Ligang, emphasized the distinct differences between health check-ups and medical consultations, stating that health check-ups focus on disease prevention and risk identification, while medical consultations aim for definitive diagnoses and treatments [3][4][8]. - He noted that if health check-ups were conducted in the same manner as medical consultations, they would be prohibitively expensive, making it impractical for consumers [3][4][8]. - The company highlighted that the public's understanding of the boundaries between health check-ups and medical consultations is currently unclear, despite established definitions by the Chinese Medical Association [3][4][8]. Group 2: Response to Media Misrepresentation - iKang Group issued a statement asserting that certain media outlets misrepresented the CEO's comments by taking them out of context, which has severely harmed the company's reputation [3][4][6]. - The company maintains that it will continue to provide professional health management services regardless of the price of health check-up packages, reaffirming its commitment to customer service [5][9]. - iKang Group reserves the right to pursue legal action against media entities that engage in such misrepresentation [6].

Core Viewpoint - The statement from Aikang Group clarifies that the media misrepresented CEO Zhang Ligang's comments regarding the differences between health check-ups and medical consultations, emphasizing that the two serve distinct purposes and should not be conflated [1][2]. Group 1: Media Misrepresentation - Aikang Group asserts that certain media outlets distorted CEO Zhang Ligang's remarks by taking them out of context, leading to misleading headlines that undermine the value of health check-ups [1][2]. - The CEO's comments were intended to highlight the differences between preventive health check-ups and targeted medical consultations, which are fundamentally different in purpose and cost [2]. Group 2: Commitment to Professionalism - Aikang Group emphasizes its commitment to providing professional health management services, regardless of the price of health check-up packages, and will not compromise on service quality [3]. - The company maintains that the misrepresentation of its statements violates the principles of comprehensive news reporting and has harmed its reputation, reserving the right to pursue legal action against the offending media [3].

Core Viewpoint - Aikang Group held a media briefing to address the recent controversy regarding a patient, Ms. Zhang, who claimed that her kidney cancer was not detected during ten years of health check-ups. The company denied any malpractice and announced a formal lawsuit against Ms. Zhang for defamation [1][3]. Group 1: Company Response - Aikang Group refuted allegations of diagnostic errors in Ms. Zhang's kidney examinations and stated that her claims about the ultrasound report were fabricated [3]. - The company emphasized that early diagnosis of kidney cancer primarily relies on imaging techniques (CT/MRI) rather than blood tests, as per the NCCN guidelines [3]. - Aikang Group provided evidence of quality control for Ms. Zhang's cancer marker tests, asserting that all data is traceable and available for government verification [3][4]. Group 2: Medical Practices and Regulations - Aikang Group explained that the preservation period for blood samples is typically 1-7 days, making it impossible to provide ten years' worth of samples as requested by Ms. Zhang [4]. - The company confirmed that all medical personnel are certified and that all equipment and reagents comply with national regulations, ensuring strict adherence to quality control standards [4]. Group 3: Patient History and Diagnosis - Aikang Group outlined Ms. Zhang's medical history, indicating that her ultrasound in October 2023 suggested possible kidney tumors, and subsequent tests led to a diagnosis of early-stage kidney cancer in November 2024 [5]. - It was noted that Ms. Zhang was later diagnosed with metastatic kidney cancer in February 2025 after further examinations [5]. Group 4: Public Perception and Misunderstanding - Aikang Group's CEO highlighted the public's misconceptions regarding the capabilities of routine health check-ups, stating that a basic health check cannot replace comprehensive medical diagnostics [7]. - The CEO pointed out that the cost of routine check-ups is significantly lower than that of specialized medical consultations, which may lead to unrealistic expectations from patients [7].